nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCND3—endocardium—dilated cardiomyopathy	0.0653	0.146	CbGeAlD
Dalfampridine—KCNQ1—endocardium—dilated cardiomyopathy	0.0632	0.141	CbGeAlD
Dalfampridine—KCNB1—pulmonary artery—dilated cardiomyopathy	0.054	0.121	CbGeAlD
Dalfampridine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0468	0.105	CbGeAlD
Dalfampridine—KCNA5—pulmonary artery—dilated cardiomyopathy	0.0355	0.0794	CbGeAlD
Dalfampridine—KCNS3—pulmonary artery—dilated cardiomyopathy	0.0348	0.0777	CbGeAlD
Dalfampridine—KCNH2—endocardium—dilated cardiomyopathy	0.0241	0.0539	CbGeAlD
Dalfampridine—KCNA7—heart—dilated cardiomyopathy	0.0118	0.0264	CbGeAlD
Dalfampridine—KCNG3—heart—dilated cardiomyopathy	0.00853	0.0191	CbGeAlD
Dalfampridine—KCNA5—cardiac ventricle—dilated cardiomyopathy	0.00738	0.0165	CbGeAlD
Dalfampridine—KCNA4—heart—dilated cardiomyopathy	0.00696	0.0156	CbGeAlD
Dalfampridine—KCNC4—heart—dilated cardiomyopathy	0.00633	0.0141	CbGeAlD
Dalfampridine—KCND1—heart—dilated cardiomyopathy	0.00633	0.0141	CbGeAlD
Dalfampridine—KCND2—cardiac ventricle—dilated cardiomyopathy	0.0063	0.0141	CbGeAlD
Dalfampridine—KCNC1—heart—dilated cardiomyopathy	0.00608	0.0136	CbGeAlD
Dalfampridine—KCNQ4—heart—dilated cardiomyopathy	0.00608	0.0136	CbGeAlD
Dalfampridine—KCNC4—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNH5—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCND1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNH8—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNH1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA7—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNV2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNC3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNF1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNH4—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNV1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNB2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA10—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNS1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNG1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA4—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNS2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA6—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNC1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNG3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCNA5—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00554	0.0118	CbGpPWpGaD
Dalfampridine—KCND3—cardiac ventricle—dilated cardiomyopathy	0.00549	0.0123	CbGeAlD
Dalfampridine—KCND3—myocardium—dilated cardiomyopathy	0.00517	0.0116	CbGeAlD
Dalfampridine—KCNQ1—myocardium—dilated cardiomyopathy	0.005	0.0112	CbGeAlD
Dalfampridine—KCNA3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00494	0.0105	CbGpPWpGaD
Dalfampridine—KCNA5—heart—dilated cardiomyopathy	0.00485	0.0108	CbGeAlD
Dalfampridine—KCNS3—heart—dilated cardiomyopathy	0.00475	0.0106	CbGeAlD
Dalfampridine—KCNQ3—heart—dilated cardiomyopathy	0.00475	0.0106	CbGeAlD
Dalfampridine—KCNQ4—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00471	0.01	CbGpPWpGaD
Dalfampridine—KCNQ5—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00471	0.01	CbGpPWpGaD
Dalfampridine—KCNA5—cardiac atrium—dilated cardiomyopathy	0.00415	0.00927	CbGeAlD
Dalfampridine—KCND2—heart—dilated cardiomyopathy	0.00414	0.00925	CbGeAlD
Dalfampridine—KCNQ3—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00405	0.0086	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00405	0.0086	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00398	0.00846	CbGpPWpGaD
Dalfampridine—KCNG2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00395	0.00839	CbGpPWpGaD
Dalfampridine—KCNS3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00395	0.00839	CbGpPWpGaD
Dalfampridine—KCNC2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00395	0.00839	CbGpPWpGaD
Dalfampridine—KCND3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00384	0.00816	CbGpPWpGaD
Dalfampridine—KCNB1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00374	0.00796	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00369	0.00785	CbGpPWpGaD
Dalfampridine—KCND3—heart—dilated cardiomyopathy	0.00361	0.00806	CbGeAlD
Dalfampridine—KCNQ1—heart—dilated cardiomyopathy	0.00349	0.00781	CbGeAlD
Dalfampridine—KCNH7—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00348	0.00739	CbGpPWpGaD
Dalfampridine—KCNQ1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00342	0.00728	CbGpPWpGaD
Dalfampridine—KCND2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00342	0.00728	CbGpPWpGaD
Dalfampridine—KCNH6—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00336	0.00714	CbGpPWpGaD
Dalfampridine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00326	0.0396	CcSEcCtD
Dalfampridine—KCND3—cardiac atrium—dilated cardiomyopathy	0.00308	0.0069	CbGeAlD
Dalfampridine—KCNA1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00304	0.00645	CbGpPWpGaD
Dalfampridine—KCNH7—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00299	0.00636	CbGpPWpGaD
Dalfampridine—KCNQ1—cardiac atrium—dilated cardiomyopathy	0.00299	0.00668	CbGeAlD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00298	0.00634	CbGpPWpGaD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0029	0.00617	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00263	0.00559	CbGpPWpGaD
Dalfampridine—KCNQ2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00254	0.00541	CbGpPWpGaD
Dalfampridine—KCNQ3—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00254	0.00541	CbGpPWpGaD
Dalfampridine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00254	0.0309	CcSEcCtD
Dalfampridine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00252	0.0307	CcSEcCtD
Dalfampridine—KCNB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—ABCC9—dilated cardiomyopathy	0.00242	0.00514	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00232	0.00493	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.00226	0.0048	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00218	0.0265	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00216	0.00458	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00208	0.0253	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00207	0.00439	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00206	0.00437	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00206	0.00437	CbGpPWpGaD
Dalfampridine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00203	0.00453	CbGeAlD
Dalfampridine—Urticaria—Spironolactone—dilated cardiomyopathy	0.002	0.0244	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00197	0.00419	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00197	0.00419	CbGpPWpGaD
Dalfampridine—KCNH2—myocardium—dilated cardiomyopathy	0.00191	0.00426	CbGeAlD
Dalfampridine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00187	0.0228	CcSEcCtD
Dalfampridine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00186	0.0226	CcSEcCtD
Dalfampridine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00175	0.0213	CcSEcCtD
Dalfampridine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00174	0.0212	CcSEcCtD
Dalfampridine—KCNC2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00172	0.00366	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00172	0.00366	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00172	0.00366	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00168	0.00356	CbGpPWpGaD
Dalfampridine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00167	0.0203	CcSEcCtD
Dalfampridine—KCNC2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00165	0.00351	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00165	0.00351	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00165	0.00351	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00163	0.00347	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00161	0.00342	CbGpPWpGaD
Dalfampridine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0016	0.0195	CcSEcCtD
Dalfampridine—Rash—Spironolactone—dilated cardiomyopathy	0.00159	0.0193	CcSEcCtD
Dalfampridine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00159	0.0193	CcSEcCtD
Dalfampridine—Headache—Spironolactone—dilated cardiomyopathy	0.00158	0.0192	CcSEcCtD
Dalfampridine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00157	0.0191	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00157	0.00333	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SCN5A—dilated cardiomyopathy	0.00153	0.00325	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SCN5A—dilated cardiomyopathy	0.00153	0.00325	CbGpPWpGaD
Dalfampridine—Nausea—Spironolactone—dilated cardiomyopathy	0.0015	0.0182	CcSEcCtD
Dalfampridine—KCNQ1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00149	0.00318	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00149	0.00318	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00147	0.00312	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00144	0.00306	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00144	0.00306	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00143	0.00305	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00143	0.00305	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00142	0.0173	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00141	0.003	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00141	0.00299	CbGpPWpGaD
Dalfampridine—Confusional state—Furosemide—dilated cardiomyopathy	0.00138	0.0168	CcSEcCtD
Dalfampridine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00137	0.0167	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00137	0.0029	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00134	0.0164	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00133	0.00283	CbGpPWpGaD
Dalfampridine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00133	0.0162	CcSEcCtD
Dalfampridine—KCNH2—heart—dilated cardiomyopathy	0.00133	0.00298	CbGeAlD
Dalfampridine—KCNA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00133	0.00282	CbGpPWpGaD
Dalfampridine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00131	0.016	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00131	0.00278	CbGpPWpGaD
Dalfampridine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00131	0.0159	CcSEcCtD
Dalfampridine—Hypotension—Furosemide—dilated cardiomyopathy	0.00128	0.0156	CcSEcCtD
Dalfampridine—KCNA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00127	0.0027	CbGpPWpGaD
Dalfampridine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00127	0.0154	CcSEcCtD
Dalfampridine—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00127	0.00269	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00125	0.00266	CbGpPWpGaD
Dalfampridine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00123	0.015	CcSEcCtD
Dalfampridine—Back pain—Lisinopril—dilated cardiomyopathy	0.00122	0.0148	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.0012	0.00256	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00118	0.0144	CcSEcCtD
Dalfampridine—Tremor—Lisinopril—dilated cardiomyopathy	0.00118	0.0144	CcSEcCtD
Dalfampridine—Constipation—Furosemide—dilated cardiomyopathy	0.00117	0.0143	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00117	0.00248	CbGpPWpGaD
Dalfampridine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00115	0.014	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00114	0.00243	CbGpPWpGaD
Dalfampridine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00114	0.00255	CbGeAlD
Dalfampridine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00113	0.0137	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00111	0.00236	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00111	0.00236	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00109	0.00232	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00109	0.00232	CbGpPWpGaD
Dalfampridine—Urticaria—Furosemide—dilated cardiomyopathy	0.00109	0.0133	CcSEcCtD
Dalfampridine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00107	0.0131	CcSEcCtD
Dalfampridine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00107	0.013	CcSEcCtD
Dalfampridine—KCNQ3—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00107	0.00227	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00107	0.00227	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00107	0.013	CcSEcCtD
Dalfampridine—KCNQ3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00106	0.00226	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00106	0.00226	CbGpPWpGaD
Dalfampridine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00104	0.0126	CcSEcCtD
Dalfampridine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00103	0.0125	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00103	0.00218	CbGpPWpGaD
Dalfampridine—Infection—Lisinopril—dilated cardiomyopathy	0.00102	0.0124	CcSEcCtD
Dalfampridine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00101	0.0123	CcSEcCtD
Dalfampridine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000999	0.0122	CcSEcCtD
Dalfampridine—Asthenia—Furosemide—dilated cardiomyopathy	0.000984	0.012	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000974	0.00207	CbGpPWpGaD
Dalfampridine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000961	0.0117	CcSEcCtD
Dalfampridine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000931	0.0113	CcSEcCtD
Dalfampridine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000924	0.0112	CcSEcCtD
Dalfampridine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000917	0.0112	CcSEcCtD
Dalfampridine—Dizziness—Furosemide—dilated cardiomyopathy	0.000907	0.011	CcSEcCtD
Dalfampridine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000906	0.011	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000891	0.00189	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000888	0.0108	CcSEcCtD
Dalfampridine—Constipation—Lisinopril—dilated cardiomyopathy	0.00088	0.0107	CcSEcCtD
Dalfampridine—Vomiting—Furosemide—dilated cardiomyopathy	0.000872	0.0106	CcSEcCtD
Dalfampridine—Rash—Furosemide—dilated cardiomyopathy	0.000865	0.0105	CcSEcCtD
Dalfampridine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000864	0.0105	CcSEcCtD
Dalfampridine—Headache—Furosemide—dilated cardiomyopathy	0.000859	0.0105	CcSEcCtD
Dalfampridine—KCNQ3—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000858	0.00182	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000858	0.00182	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000848	0.0103	CcSEcCtD
Dalfampridine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000817	0.00994	CcSEcCtD
Dalfampridine—Nausea—Furosemide—dilated cardiomyopathy	0.000815	0.00991	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000798	0.0017	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000758	0.00922	CcSEcCtD
Dalfampridine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000738	0.00898	CcSEcCtD
Dalfampridine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00068	0.00828	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000674	0.00143	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000674	0.00143	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000674	0.00143	CbGpPWpGaD
Dalfampridine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000654	0.00796	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000652	0.00139	CbGpPWpGaD
Dalfampridine—Rash—Lisinopril—dilated cardiomyopathy	0.000649	0.00789	CcSEcCtD
Dalfampridine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000648	0.00788	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—PSEN2—dilated cardiomyopathy	0.000645	0.00137	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PSEN2—dilated cardiomyopathy	0.000645	0.00137	CbGpPWpGaD
Dalfampridine—Headache—Lisinopril—dilated cardiomyopathy	0.000645	0.00784	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000639	0.00136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TAZ—dilated cardiomyopathy	0.000633	0.00135	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TAZ—dilated cardiomyopathy	0.000633	0.00135	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TAZ—dilated cardiomyopathy	0.000633	0.00135	CbGpPWpGaD
Dalfampridine—Nausea—Lisinopril—dilated cardiomyopathy	0.000611	0.00743	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—TAZ—dilated cardiomyopathy	0.0006	0.00128	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SDHA—dilated cardiomyopathy	0.000573	0.00122	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SDHA—dilated cardiomyopathy	0.000573	0.00122	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SDHA—dilated cardiomyopathy	0.000573	0.00122	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00057	0.00121	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000553	0.00118	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SDHA—dilated cardiomyopathy	0.000543	0.00115	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00053	0.00113	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—RAF1—dilated cardiomyopathy	0.000528	0.00112	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—RAF1—dilated cardiomyopathy	0.00047	0.001	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00046	0.000978	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00046	0.000978	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—RAF1—dilated cardiomyopathy	0.000449	0.000954	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—RAF1—dilated cardiomyopathy	0.000449	0.000954	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ITGB1—dilated cardiomyopathy	0.000403	0.000857	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ITGB1—dilated cardiomyopathy	0.000403	0.000857	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00039	0.000829	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00039	0.000829	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00039	0.000829	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00038	0.000808	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000376	0.000799	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—RAF1—dilated cardiomyopathy	0.000376	0.000799	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—RAF1—dilated cardiomyopathy	0.000376	0.000799	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—RAF1—dilated cardiomyopathy	0.000366	0.000777	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000356	0.000758	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000339	0.000721	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00033	0.000701	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—RAF1—dilated cardiomyopathy	0.000326	0.000693	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—RAF1—dilated cardiomyopathy	0.000326	0.000693	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAC1—dilated cardiomyopathy	0.000324	0.000689	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RAC1—dilated cardiomyopathy	0.000324	0.000689	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—RAF1—dilated cardiomyopathy	0.00032	0.00068	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000289	0.000615	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000288	0.000612	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000288	0.000612	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—RAF1—dilated cardiomyopathy	0.000285	0.000606	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CD36—dilated cardiomyopathy	0.000245	0.000522	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CD36—dilated cardiomyopathy	0.000245	0.000522	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—RAF1—dilated cardiomyopathy	0.000242	0.000515	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—RAF1—dilated cardiomyopathy	0.000242	0.000515	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAC1—dilated cardiomyopathy	0.000231	0.000492	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAC1—dilated cardiomyopathy	0.000231	0.000492	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RAF1—dilated cardiomyopathy	0.000215	0.000457	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAF1—dilated cardiomyopathy	0.000215	0.000457	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—dilated cardiomyopathy	0.000156	0.000331	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—dilated cardiomyopathy	0.000156	0.000331	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—dilated cardiomyopathy	0.000156	0.000331	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—dilated cardiomyopathy	0.000153	0.000326	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—dilated cardiomyopathy	0.000153	0.000326	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD36—dilated cardiomyopathy	0.000152	0.000322	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD36—dilated cardiomyopathy	0.000152	0.000322	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD36—dilated cardiomyopathy	0.000152	0.000322	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—dilated cardiomyopathy	0.000147	0.000314	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—dilated cardiomyopathy	0.000147	0.000313	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—dilated cardiomyopathy	0.000147	0.000313	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD36—dilated cardiomyopathy	0.000144	0.000305	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AGT—dilated cardiomyopathy	0.000136	0.00029	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AGT—dilated cardiomyopathy	0.000136	0.00029	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AGT—dilated cardiomyopathy	0.000136	0.00029	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AGT—dilated cardiomyopathy	0.000129	0.000275	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000125	0.000267	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	0.000121	0.000256	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—dilated cardiomyopathy	0.000105	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—dilated cardiomyopathy	0.000105	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—dilated cardiomyopathy	0.0001	0.000213	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—dilated cardiomyopathy	0.0001	0.000213	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	9.79e-05	0.000208	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	9.2e-05	0.000196	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	8.32e-05	0.000177	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	2.26e-05	4.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	2.2e-05	4.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.98e-05	4.21e-05	CbGpPWpGaD
